a month ago
AXSM
AnalystsAshwani VermaAshwani Verma's Stock Forecasts
AnalystsAshwani Verma
Analyst Ranking
Top 15%
#731 out of 5185 analysts
Average Return
+11.41%
Win Rate
56%46 out of 82
Risk vs Reward
Poor
Good
Ashwani Verma's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcellx IncACLX | +164.51% | $35.16 | $93.00 | 2023-10-17 - 2024-10-16 | Strong Buy |
Avadel Pharmaceuticals PLCAVDL | +137.72% | $7.82 | $18.59 | 2025-01-13 - 2025-10-28 | Strong Buy |
Cytokinetics IncCYTK | +116.84% | $37.71 | $81.77 | 2023-04-03 - 2024-01-24 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +105.80% | $16.56 | $34.08 | 2025-06-26 - 2026-01-30 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +85.37% | $17.84 | $33.07 | 2025-01-30 - 2026-01-29 | Strong Buy |
Ashwani Verma Analyst Color
Get additional color on Ashwani Verma's coverage of popular stocks
2 months ago
JAZZ
3 months ago
ABBV
4 months ago
NBIX
4 months ago
TEVA
2 years ago
TEVA
2 years ago
LEGN
2 years ago
ITCI
Ashwani Verma's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | 11 | Strong Buy | $178.00 | +30.82% | Maintains | 9 days ago |
Insmed IncINSM | 1 | Strong Buy | $215.00 | +37.06% | Maintains | a month ago |
United Therapeutics CorpUTHR | 11 | Strong Buy | $645.00 | +37.38% | Maintains | a month ago |
Axsome Therapeutics IncAXSM | 6 | Strong Buy | $248.00 | +34.60% | Maintains | a month ago |
Acadia Pharmaceuticals IncACAD | 9 | Strong Buy | $40.00 | +59.17% | Maintains | a month ago |
Corcept Therapeutics IncCORT | 1 | Hold | $95.00 | +138.27% | Initiates Coverage On | 2 months ago |
Legend Biotech CorpLEGN | 4 | Strong Buy | $48.00 | +174.29% | Maintains | 2 months ago |
Biohaven LtdBHVN | 5 | Hold | $11.00 | -7.02% | Downgrades | 2 months ago |
Jazz Pharmaceuticals PLCJAZZ | 7 | Hold | $188.00 | +14.29% | Downgrades | 2 months ago |
AlvotechALVO | 1 | Strong Buy | $10.00 | +86.22% | Maintains | 2 months ago |
Abbvie IncABBV | 1 | Hold | $220.00 | -1.35% | Maintains | 3 months ago |
Exelixis IncEXEL | 5 | Hold | $40.00 | -3.29% | Maintains | 3 months ago |
Avadel Pharmaceuticals PLCAVDL | 4 | Hold | $20.00 | -7.19% | Downgrades | 3 months ago |
Harmony Biosciences Holdings IncHRMY | 3 | Strong Buy | $43.00 | +17.74% | Maintains | 4 months ago |
Teva Pharmaceutical Industries LtdTEVA | 10 | Strong Buy | $26.00 | -23.71% | Maintains | 4 months ago |
Incyte CorpINCY | 2 | Hold | $68.00 | -32.05% | Maintains | 6 months ago |
Immunovant IncIMVT | 1 | Hold | $18.00 | -30.77% | Maintains | 6 months ago |
Alkermes PLCALKS | 4 | Strong Buy | $42.00 | +23.93% | Upgrades | 7 months ago |
Cytokinetics IncCYTK | 5 | Hold | $41.00 | -35.12% | Maintains | 9 months ago |
Coherus Oncology IncCHRS | 5 | Hold | $1.05 | -51.39% | Maintains | 9 months ago |
Arcellx IncACLX | 2 | Strong Buy | $114.00 | N/A | Maintains | a year ago |
Intra Cellular Therapies IncITCI | 5 | Hold | $79.00 | N/A | Maintains | a year ago |
Royalty Pharma PLCRPRX | 3 | Hold | $28.00 | N/A | Downgrades | 2 years ago |
Coherent CorpCOHR | 1 | Strong Buy | $7.00 | N/A | Maintains | 2 years ago |
Karuna Therapeutics IncKRTX | 2 | Hold | $209.00 | N/A | Initiates Coverage On | 3 years ago |
Viatris IncVTRS | 2 | Hold | $12.00 | N/A | Upgrades | 3 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Hold | $71.00 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.